NEWS

YM BioSciences and Oncoscience Report Response Rate of 35.3% in Pediatric Glioma

ByOncoscience 1. March 2005

NEWS

YM Biosciences and Oncoscience AG achieve clinical milestone

ByOncoscience 10. January 2005

NEWS

Oncoscience AG announced a change in the board of directors

ByOncoscience 15. October 2004

NEWS

Oncoscience AG established scientific advisory board

ByOncoscience 15. October 2004

NEWS

YM BioSciences’ EGFr antibody receives EU orphan drug designation through Oncoscience AG, its European partner

ByOncoscience 10. August 2004

NEWS

Orphan-Drug-Designation finalised

ByOncoscience 30. June 2004

NEWS

AACR annual meeting 2004 – Late breaking news

ByOncoscience 15. March 2004

NEWS

Oncoscience signs contract with YM Biosciences Inc.

ByOncoscience 15. November 2003